Patients in the taper group reported more days per week of illicit opioid use than those in the maintenance group once they were no longer receiving buprenorphine ( mean use , 1.27 [ 95 % CI , 0.60-1 .94 ] vs 0.47 [ 95 % CI , 0.19-0 .74 ] days ) .